Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AAA Endografts “Preferable” To Open Repair – DREAM Study

This article was originally published in The Gray Sheet

Executive Summary

A reduced operative mortality rate associated with endovascular abdominal aortic aneurysm (AAA) repair, compared with open surgical treatment, highlights the need for long-term data, according to an editorial in the Oct. 14 New England Journal of Medicine

You may also be interested in...



Jury Still Out On EVAR Versus Open Surgery For Abdominal Aortic Aneurysm

Proponents of endovascular repair for abdominal aortic aneurysm (AAA) have yet to prove that the less invasive procedure is any better than open surgical repair, although mixed study results signal that the jury is still out

Jury Still Out On EVAR Versus Open Surgery For Abdominal Aortic Aneurysm

Proponents of endovascular repair for abdominal aortic aneurysm (AAA) have yet to prove that the less invasive procedure is any better than open surgical repair, although mixed study results signal that the jury is still out

AE Rates For Powerlink AAA Graft Lower Than For Predecessors – Endologix

Endologix will file data with FDA on the first 10 Powerlink AAA endografts implanted by each physician trained on the device, under conditions of its PMA approval

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021026

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel